Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents

Candida albicans is an opportunistic pathogen that causes candidiasis in humans. In recent years, metabolic pathways in C. albicans have been explored as potential antifungal targets to treat candidiasis. The glyoxylate cycle, which enables C. albicans to survive in nutrient-limited host niches and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheah, Hong-Leong, Lim, Vuanghao, Sandai, Doblin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004578/
https://www.ncbi.nlm.nih.gov/pubmed/24781056
http://dx.doi.org/10.1371/journal.pone.0095951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004578/
https://www.ncbi.nlm.nih.gov/pubmed/24781056
http://dx.doi.org/10.1371/journal.pone.0095951

Ejemplares similares